company background image
DOCS

DoximityNYSE:DOCS Stock Report

Market Cap

US$12.1b

7D

13.7%

1Y

n/a

Updated

02 Dec, 2021

Data

Company Financials +
DOCS fundamental analysis
Snowflake Score
Valuation0/6
Future Growth3/6
Past Performance3/6
Financial Health6/6
Dividends0/6

DOCS Stock Overview

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States.

Doximity Competitors

Teladoc Health

NYSE:TDOC

US$15.0b

American Well

NYSE:AMWL

US$1.6b

Alphabet

NasdaqGS:GOOG.L

US$1.9t

Meta Platforms

NasdaqGS:FB

US$864.0b

Price History & Performance

Summary of all time highs, changes and price drops for Doximity
Historical stock prices
Current Share PriceUS$67.51
52 Week HighUS$107.79
52 Week LowUS$41.17
Beta0
1 Month Change-7.23%
3 Month Change-31.92%
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO27.38%

Recent News & Updates

Nov 22

Doximity: Better Than Teladoc, But Still Not Worth Buying

As the world continues to recover from the Covid-19 pandemic, the stocks that saw pandemic tailwinds are now fading. Doximity is a digital health network that is making strides in telemedicine. However, it appears the tide is now going out on this sort of company. Meanwhile, shares are still trading for more than 40x revenues. Doximity seems like a better investment than the more well-known Teladoc. Still, both look like bad picks for the time being.

Nov 17
Shareholders Can Be Confident That Doximity's (NYSE:DOCS) Earnings Are High Quality

Shareholders Can Be Confident That Doximity's (NYSE:DOCS) Earnings Are High Quality

Even though Doximity, Inc.'s ( NYSE:DOCS ) recent earnings release was robust, the market didn't seem to notice...

Shareholder Returns

DOCSUS Healthcare ServicesUS Market
7D13.7%-4.0%-3.5%
1Yn/a-10.4%19.4%

Return vs Industry: Insufficient data to determine how DOCS performed against the US Healthcare Services industry.

Return vs Market: Insufficient data to determine how DOCS performed against the US Market.

Price Volatility

Is DOCS's price volatile compared to industry and market?
DOCS volatility
DOCS Average Weekly Movement11.0%
Healthcare Services Industry Average Movement8.8%
Market Average Movement6.1%
10% most volatile stocks in US Market14.9%
10% least volatile stocks in US Market2.4%

Stable Share Price: DOCS is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 11% a week.

Volatility Over Time: Insufficient data to determine DOCS's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
2010799Jeff Tangneyhttps://www.doximity.com

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company’s cloud-based platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical companies and health systems.

Doximity Fundamentals Summary

How do Doximity's earnings and revenue compare to its market cap?
DOCS fundamental statistics
Market CapUS$12.14b
Earnings (TTM)US$63.27m
Revenue (TTM)US$277.42m

200.1x

P/E Ratio

45.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
DOCS income statement (TTM)
RevenueUS$277.42m
Cost of RevenueUS$32.80m
Gross ProfitUS$244.61m
ExpensesUS$181.35m
EarningsUS$63.27m

Last Reported Earnings

Sep 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)0.34
Gross Margin88.18%
Net Profit Margin22.81%
Debt/Equity Ratio0%

How did DOCS perform over the long term?

See historical performance and comparison

Valuation

Is Doximity undervalued compared to its fair value and its price relative to the market?

200.09x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: DOCS ($67.51) is trading above our estimate of fair value ($24.93)

Significantly Below Fair Value: DOCS is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: DOCS is poor value based on its PE Ratio (200.1x) compared to the US Healthcare Services industry average (97x).

PE vs Market: DOCS is poor value based on its PE Ratio (200.1x) compared to the US market (16.9x).


Price to Earnings Growth Ratio

PEG Ratio: DOCS is poor value based on its PEG Ratio (26.8x)


Price to Book Ratio

PB vs Industry: DOCS is overvalued based on its PB Ratio (16.4x) compared to the US Healthcare Services industry average (4.3x).


Future Growth

How is Doximity forecast to perform in the next 1 to 3 years based on estimates from 10 analysts?

7.5%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: DOCS's forecast earnings growth (7.5% per year) is above the savings rate (2%).

Earnings vs Market: DOCS's earnings (7.5% per year) are forecast to grow slower than the US market (14.1% per year).

High Growth Earnings: DOCS's earnings are forecast to grow, but not significantly.

Revenue vs Market: DOCS's revenue (23.4% per year) is forecast to grow faster than the US market (10% per year).

High Growth Revenue: DOCS's revenue (23.4% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: DOCS's Return on Equity is forecast to be low in 3 years time (15.1%).


Past Performance

How has Doximity performed over the past 5 years?

318.2%

Last years earnings growth


Earnings and Revenue History

Quality Earnings: DOCS has high quality earnings.

Growing Profit Margin: DOCS's current net profit margins (22.8%) are higher than last year (9.7%).


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if DOCS's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Insufficient data to compare DOCS's past year earnings growth to its 5-year average.

Earnings vs Industry: DOCS earnings growth over the past year (318.2%) exceeded the Healthcare Services industry 17%.


Return on Equity

High ROE: DOCS's Return on Equity (13.1%) is considered low.


Financial Health

How is Doximity's financial position?


Financial Position Analysis

Short Term Liabilities: DOCS's short term assets ($829.6M) exceed its short term liabilities ($95.6M).

Long Term Liabilities: DOCS's short term assets ($829.6M) exceed its long term liabilities ($1.1M).


Debt to Equity History and Analysis

Debt Level: DOCS is debt free.

Reducing Debt: DOCS has not had any debt for past 5 years.

Debt Coverage: DOCS has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: DOCS has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is Doximity current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate DOCS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate DOCS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if DOCS's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if DOCS's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of DOCS's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

6.6yrs

Average management tenure


CEO

Jeff Tangney (48 yo)

11.67yrs

Tenure

US$21,312,948

Compensation

Mr. Jeffrey A. Tangney, also known as Jeff, Co-Founded Doximity, Inc. in 2010 and serves as its Chief Executive Officer and Director since April 2010. Mr. Tangney also serves as an Advisor at Rock Health....


CEO Compensation Analysis

Compensation vs Market: Jeff's total compensation ($USD21.31M) is above average for companies of similar size in the US market ($USD11.16M).

Compensation vs Earnings: Insufficient data to compare Jeff's compensation with company performance.


Leadership Team

Experienced Management: DOCS's management team is seasoned and experienced (6.6 years average tenure).


Board Members

Experienced Board: DOCS's board of directors are considered experienced (6.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: DOCS only recently listed within the past 12 months.


Top Shareholders

Company Information

Doximity, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Doximity, Inc.
  • Ticker: DOCS
  • Exchange: NYSE
  • Founded: 2010
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: US$12.143b
  • Shares outstanding: 187.51m
  • Website: https://www.doximity.com

Number of Employees


Location

  • Doximity, Inc.
  • 500, 3rd Street
  • Suite 510
  • San Francisco
  • California
  • 94107
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/12/02 23:43
End of Day Share Price2021/12/02 00:00
Earnings2021/09/30
Annual Earnings2021/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.